Encompass Health Co. (NYSE:EHC) Short Interest Update

Encompass Health Co. (NYSE:EHC) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,350,000 shares, a growth of 6.3% from the December 31st total of 1,270,000 shares. Approximately 1.4% of the company’s stock are short sold. Based on an average daily volume of 649,300 shares, the days-to-cover ratio is currently 2.1 days.

Analysts Set New Price Targets

A number of research firms recently commented on EHC. Royal Bank of Canada increased their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Barclays raised their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, KeyCorp upped their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Stock Performance

Shares of NYSE:EHC traded up $0.51 during midday trading on Tuesday, reaching $101.09. The company’s stock had a trading volume of 127,687 shares, compared to its average volume of 596,382. The firm has a market capitalization of $10.18 billion, a PE ratio of 24.41, a P/E/G ratio of 1.18 and a beta of 0.90. The stock has a fifty day moving average of $96.49 and a 200 day moving average of $94.91. Encompass Health has a twelve month low of $70.83 and a twelve month high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Institutional Trading of Encompass Health

Hedge funds have recently modified their holdings of the stock. Point72 Asset Management L.P. boosted its position in Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock worth $83,990,000 after purchasing an additional 835,135 shares in the last quarter. Jennison Associates LLC purchased a new stake in Encompass Health during the fourth quarter worth $52,094,000. abrdn plc acquired a new stake in Encompass Health during the fourth quarter valued at $17,846,000. Thrivent Financial for Lutherans increased its holdings in Encompass Health by 26.0% in the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after buying an additional 156,938 shares in the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of Encompass Health by 22.0% during the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock worth $67,412,000 after acquiring an additional 126,000 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.